Form 8-K - Current report:
SEC Accession No. 0001104659-23-125696
Filing Date
2023-12-13
Accepted
2023-12-13 16:01:49
Documents
13
Period of Report
2023-12-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2332799d1_8k.htm   iXBRL 8-K 27791
2 EXHIBIT 10.1 tm2332799d1_ex10-1.htm EX-10.1 1344454
  Complete submission text file 0001104659-23-125696.txt   1855601

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pbh-20231208.xsd EX-101.SCH 3039
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbh-20231208_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbh-20231208_pre.xml EX-101.PRE 22376
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2332799d1_8k_htm.xml XML 3219
Mailing Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591
Business Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591 (914) 524-6800
Prestige Consumer Healthcare Inc. (Filer) CIK: 0001295947 (see all company filings)

EIN.: 201297589 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-32433 | Film No.: 231483949
SIC: 2834 Pharmaceutical Preparations